Kelly Financial Services LLC Biomarin Pharmaceutical Inc Transaction History

Kelly Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jul 17, 2024	SELL	$71.72 - $91.47 $1,434 - $1,829	-20 Closed	0 $0
Q3 2021 Jul 17, 2024	SELL	$74.77 - $85.47 $123,295 - $140,940	-1,649 Reduced 98.8%	20 $1.55 Million
Q2 2021 Jul 17, 2024	BUY	$75.51 - $84.79 $119,683 - $134,392	1,585 Added 1886.9%	1,669 $20,000
Q1 2021 Jul 17, 2024	BUY	$74.73 - $90.69 $6,277 - $7,617	84 New	84 $6.34 Million

620

183M

1.41M

1.31M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.